Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2009/051590external-prioritypatent/WO2009128043A1/en
Application filed by Onderstepoort Biolog Products LtdfiledCriticalOnderstepoort Biolog Products Ltd
Publication of TN2010000479A1publicationCriticalpatent/TN2010000479A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
The invention describes the preparation of an inactivated bluetongue virus (BTV) composition, and in particular a vaccine, using an attenuated live BTV vaccine strain as masterseed. The vaccine can be administered to an animal to prevent bluetongue disease by eliciting an immune response against the bluetongue virus serotype(s) included in the composition.
TNP2010000479A2009-04-162010-10-15Inactivated live - attenuated bluetongue virus vaccine
TN2010000479A1
(en)
rearranged influenza virus, antigenic composition of rearranged influenza virus, vaccine, and methods for eliciting an immune response to at least one pandemic influenza virus strain in an individual, to prevent infection of an individual by an influenza virus, and to prepare a vaccine .
Recombinant parapoxvirus comprising a parapoxvirus and heterologous DNA derived from a rabies virus; preparation process of said parapoxvirus; immunogenic composition; use of the composition to induce immune response against rabies virus in an animal.